CLOs on the Move


 
Aeromotive is a Overland Park, KS-based company in the Manufacturing sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

F

F is a Ithaca, NY-based company in the Manufacturing sector.

Hauser Industries

Hauser Industries Inc. is a Waterloo, ON-based company in the Manufacturing sector.

Flexiv

Flexiv Ltd. is a global leading robotics and AI company, focusing on developing and manufacturing adaptive robots which integrate force control, computer vision and AI technologies. Flexiv provides innovative turnkey solutions and services based on Flexiv robotic systems to customers in multi industries. The company started in 2016, with core founding team from robotics and AI laboratories at Stanford University. Today, Flexiv has established offices in Santa Clara, Shanghai, Shenzhen, Beijing and Foshan.

Coastal Tag and Label

Coastal Tag & Label is a Whittier, CA-based company in the Manufacturing sector.

enVVeno

enVVeno Medical (NASDAQ:NVNO) is an Irvine, California-based, late clinical-stage medical device company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The Company`s lead product, the VenoValve®, is a first-in-class surgical replacement venous valve being developed for the treatment of deep venous Chronic Venous Insufficiency (CVI). The Company is also developing a non-surgical, transcatheter based replacement venous valve for the treatment of deep venous CVI called enVVe™. CVI occurs when valves inside of the veins of the leg become damaged, resulting in the backwards flow of blood (reflux), blood pooling in the lower leg, increased pressure in the veins of the leg (venous hypertension) and in severe cases, venous ulcers that are difficult to heal and become chronic. Both the VenoValve and enVVe are designed to act as one-way valves, to help assist in propelling blood up the leg, and back to the heart and lungs. The VenoValve is currently being evaluated in the SAVVE U.S. pivotal study and the company is currently waiting for regulatory approval to begin the TAVVE first-in-human trial for enVVe.